Name: Latest research reports of Dr. Reddy's Laboratories Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Dr. Reddy's Laboratories Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Dr. Reddy's Laboratories Ltd.

NSE: DRREDDY | BSE: 500124 | ISIN: INE089A01031 | Industry: Pharmaceuticals
| Mid-range Performer

1346.8000 -15.70 (-1.15%)

NSE Jun 16, 2025 15:31 PM

32.04% Gain from 52W Low

Volume: 1.3M

Dr. Reddy's Laboratories Ltd.

30 Oct 2023

1346.80

-1.15%

Dr Reddy's Labs (HOLD): One-offs fuel PAT beat; India business still soft

Hold: Dr. Reddy's Laboratories Ltd.

Target

BOB Capital Markets Ltd.

Q2 revenue in line but PAT outdid consensus by 22% on account of PLI benefits, litigation settlement and interest income

Number of FII/FPI investors decreased from 927 to 911 in Mar 2025 qtr